Ftse Mib
34.321,92
-0,16%
DAX
18.502,60
-0,52%
S&P 500
5.631,22
0,00%
NASDAQ
18.472,57
0,00%
Bitcoin
63.850,01
-1,54%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Italia BIT Abitare In Spa (ABT) Abitare In Spa (ABT) Notizie

ABT

Abitare In (ABT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:BIT:ABT
DataOraFonteTitoloSimboloCompagnia
13/09/200715:15PR Newswire (US)Abbott Awards Arizona Mother $135,000 in National Similac(R) ContestBIT:ABT
31/08/200715:01PR Newswire (US)Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose CombinationBIT:ABT
29/06/200700:36PR Newswire (US)Abbott and Abbott Fund Expand Commitment to Improving Health Care in Tanzania With Dedication of New Lab and Launch of New DiagnBIT:ABT
13/06/200715:15PR Newswire (US)Global Business Coalition on HIV/AIDS, TB and Malaria (GBC) Honors Abbott and Abbott Fund for Efforts to Fight HIV/AIDS in TanzaBIT:ABT
12/06/200721:25PR Newswire (US)Abbott to Present at Goldman Sachs Healthcare ConferenceBIT:ABT
04/06/200717:36PR Newswire (US)First Bright Space Developed to Give Children Living With Substance Abuse a Dedicated Play and Learning EnvironmentBIT:ABT
27/04/200713:27PR Newswire (US)Abbott's HUMIRA(R) (Adalimumab) Receives Positive Opinion from European Medicines Agency for the Treatment of Crohn.s DiseaseBIT:ABT
25/04/200716:01PR Newswire (US)Abbott to Present at Morgan Stanley Healthcare ConferenceBIT:ABT
23/04/200718:00PR Newswire (US)Abbott and Abbott Fund Provide $1 Million to HealthReach to Increase Access to Care and Expand Services at Area's Only Free HealBIT:ABT
02/04/200715:00PR Newswire (US)Abbott Seeks U.S. and E.U. Regulatory Approval for HUMIRA(R) (Adalimumab) in PsoriasisBIT:ABT
24/03/200717:00PR Newswire (US)Abbott Announces Positive Six-Month Results From the World's First Clinical Trial of a Fully Bioabsorbable Drug-Eluting CoronaryBIT:ABT
23/03/200722:57PR Newswire (US)Abbott Named to DiversityInc's 'Top 50 Companies for Diversity' ListBIT:ABT
05/03/200716:01PR Newswire (US)Abbott Donates Diagnostic Equipment and Supplies to 16 Clinical Laboratory Programs as Part of 'Labs are Vital(TM)' InitiativeBIT:ABT
22/01/200716:00PR Newswire (US)Abbott Nutrition to Host 'The ZonePerfect(R) Bar' Music Series at 2007 Sundance Film FestivalBIT:ABT
11/01/200714:50PR Newswire (US)Private-Label Version of Abbott's XIENCE(TM)V Drug-Eluting Coronary Stent System Launches in EuropeBIT:ABT
14/12/200614:45PR Newswire (US)Abbott Fund Supports Pioneering Malaria Education ProgramBIT:ABT
28/11/200616:15PR Newswire (US)Children Affected by HIV/AIDS Around the World Bring Their Photographs and Stories to Chicago for the First TimeBIT:ABT
23/10/200615:00PR Newswire (US)New Phase III Data Shows Abbott's HUMIRA(R) (Adalimumab) Induced Clinical Remission In Patients With Crohn's Disease Who Lost ReBIT:ABT
22/08/200617:10PR Newswire (US)Rising Medical Costs Biggest Challenge for Diabetes Patients in Managing the ConditionBIT:ABT
02/08/200621:46PR Newswire (US)S&P Equity Research Has Positive View on New Medicare Medical Device Reimbursement RulesBIT:ABT
19/07/200621:00PR Newswire (US)Abbott Announces FDA Clearance of Cell-Dyn Ruby(TM) Hematology InstrumentBIT:ABT
09/05/200615:00PR Newswire (US)Abbott to Present at Banc of America Securities Health Care ConferenceBIT:ABT
28/04/200614:30PR Newswire (US)Abbott's HUMIRA(R) (Adalimumab) Receives Positive Opinion From European Medicines Agency for the Treatment of Ankylosing SpondyBIT:ABT
11/11/200503:06PR Newswire (US)U.S. District Court Grants Abbott's Request for a Preliminary Injunction Against Biaxin(R) XL GenericsBIT:ABT
31/10/200514:04PR Newswire (US)Abbott Receives FDA Approval for New Kaletra(R) (Lopinavir/Ritonavir) Tablet Formulation for HIV PatientsBIT:ABT
24/08/200514:00PR Newswire (US)Wal-Mart Hosts Child Safety Education Event NationwideBIT:ABT
09/07/200507:21PR Newswire (US)Abbott Statement on Agreement With Brazilian Government for Kaletra(R) (Lopinavir/Ritonavir)BIT:ABT
14/06/200523:00PR Newswire (US)Getting Arms Around Childhood Obesity Focus of Colorado SummitBIT:ABT
10/06/200518:54PR Newswire (US)Abbott Declares 326th Consecutive Quarterly DividendBIT:ABT
12/05/200517:55PR Newswire (US)Recent College Graduates Find Success at AbbottBIT:ABT
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:BIT:ABT

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
FBK
Finecobank
BIT
STLAM
Stellantis NV
BIT
RACE
Ferrari NV
BIT
PRY
Prysmian
BIT
BC
Brunello Cucinelli
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
SPM
Saipem
BIT
BPE
Bper Banca
BIT
G
Generali
BIT
STMMI
ST Microelectronics
BIT
LDO
Leonardo
BIT
MONC
Moncler
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network